Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-05
2010-02-09
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S602000, C548S255000
Reexamination Certificate
active
07659293
ABSTRACT:
The invention relates to α-amino-N-hydroxy-acetamide derivatives of formula I,wherein R is di-lower alkyl amino, 1,2,3-triazol-1-yl, 1,2,3-triazol-2-yl or 1,2,4-triazol-4-yl, m represents an integer from 1 up to and including 10, and n represents an integer from 0 up to and including 10, and salts thereof:to processes for their preparation, pharmaceutical compositions comprising said hydroxamic acid derivatives, the use of such hydroxamic acid derivatives as medicaments, and a method of treating conditions or diseases mediated by matrix-degrading metalloproteinases (MMP's) using said derivatives alone or in combination with one or more other therapeutic agents.
REFERENCES:
patent: 2513826 (1950-07-01), Sprung et al.
patent: 4806528 (1989-02-01), Hanreich
patent: 5338755 (1994-08-01), Wagnon et al.
patent: 5455258 (1995-10-01), MacPherson et al.
patent: 5500337 (1996-03-01), Benard et al.
patent: 5663431 (1997-09-01), Di Malta et al.
patent: 5932695 (1999-08-01), Floyd et al.
patent: 6150394 (2000-11-01), Watanabe et al.
patent: 6159995 (2000-12-01), Thorwart et al.
patent: 6451824 (2002-09-01), Thorwart et al.
patent: 7112611 (2006-09-01), Hayakawa et al.
patent: 7291634 (2007-11-01), Hayakawa et al.
patent: 308860 (1989-03-01), None
patent: 0877019 (1998-11-01), None
patent: 915086 (1999-05-01), None
patent: 0950656 (1999-10-01), None
patent: 0877018 (2007-10-01), None
patent: 11-236369 (1999-08-01), None
patent: WO9600214 (1996-01-01), None
patent: WO9818754 (1998-05-01), None
patent: WO9825597 (1998-06-01), None
patent: WO9833768 (1998-08-01), None
patent: WO9906340 (1999-02-01), None
patent: WO99/42443 (1999-08-01), None
patent: WO0037436 (2000-01-01), None
patent: WO0044709 (2000-08-01), None
patent: WO0044713 (2000-08-01), None
patent: WO01/10827 (2001-02-01), None
Scozzaffava et al., “Protease Inhibitors: Synthesis of Potent Bacterial Collagenase and Matrix Metalloproteinase Inhibitors . . . ” J. Med. Chem., vol. 43, No. 9, pp. 1858-1865. (2000).
Casini et al, “Sulfonamides and Sulfonylated Derivatives as Anticancer Agents”, Current Cancer Drug Targets, vol. 2, pp. 55-75, (2002).
Tamura, et al., “Highly Selective and Orally Active Inhibitors of Type IV Collagenase . . . ”, vol. 41, pp. 640-549 (1998).
MacPherson et al., “Discovery of CGS 27023A, non-Peptidic, Potent and Orally Active Stromelysin Inhibitor . . . ”, J. Med. Chem., vol. 40, pp. 2525-2532 (1997).
Connell et al., “Patent Focus on Cancer Chemotherapeutics . . . ”, vol. 11(1), pp. 77-114, Apr.-Sep. (2000).
Uhlenbroek et al., “Investigations on Agricultural Fungicides . . . ”, Recl. Trav. Chim. PAYS-BAS, vol. 75, pp. 129-146 (1956).
Hayakawa Kenji
Iwasaki Genji
Koizumi Shin-ichi
Umemura Ichiro
Alexander John
Chung Susannah
Novartis AG
Shameem Golam M. M.
LandOfFree
α-Amino-N-hydroxy-acetamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with α-Amino-N-hydroxy-acetamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and α-Amino-N-hydroxy-acetamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4183909